Evidence map›Paper›PMID 38937759›Full record

ArticleHarm reduction journal2024

Using qualitative system dynamics modeling to understand overdose bystander behavior in the context of Connecticut's Good Samaritan Laws and identify effective policy options.

Rachel L Thompson, Nasim S Sabounchi, Syed Shayan Ali, Robert Heimer, Gail D'Onofrio, Rebekah Heckmann

Abstract read
In one paragraph

Article in Harm reduction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rachel L ThompsonCenter for Systems and Community Design, City University of New York Graduate School of Public Health and Health Policy, 55 West 125th Street, New York, NY, 10027, USA.ORCID 0000-0002-3042-7887
Nasim S SabounchiCenter for Systems and Community Design, City University of New York Graduate School of Public Health and Health Policy, 55 West 125th Street, New York, NY, 10027, USA.ORCID 0000-0002-8027-8779
Syed Shayan AliUniversity of Pittsburgh Medical Center, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.
Robert HeimerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, 60 College Street, New Haven, CT, 06520, USA.ORCID 0000-0003-0589-6697
Gail D'OnofrioDepartment of Emergency Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 065108, USA.
Rebekah HeckmannDepartment of Emergency Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 065108, USA. rebekah.heckmann@yale.edu.

Funding

Using System Dynamics Modeling to Foster Real-time Connections to CareR61DA057675 · NIDA · YALE UNIVERSITY · PI HECKMANN, REBEKAH, S. SABOUNCHI, NASIM · 2022 to 2023
$1.4M
STRENGTHENING PRESCRIPTION DRUG OVERDOSE PREVENTION EFFORTS IN CTU17CE002720 · CE · CONNECTICUT STATE DEPT OF PUBLIC HEALTH · PI OKEKE, CHINEDU RAPHAEL · 2016 to 2016
$1.3M
CDC HHS 1U17CE002720-02NCIPC CDC HHS U17 CE002720
6 · The paper itself

Abstract

backgroundGood Samaritan Laws are a harm reduction policy intended to facilitate a reduction in fatal opioid overdoses by enabling bystanders, first responders, and health care providers to assist individuals experiencing an overdose without facing civil or criminal liability. However, Good Samaritan Laws may not be reaching their full impact in many communities due to a lack of knowledge of protections under these laws, distrust in law enforcement, and fear of legal consequences among potential bystanders. The purpose of this study was to develop a systems-level understanding of the factors influencing bystander responses to opioid overdose in the context of Connecticut's Good Samaritan Laws and identify high-leverage policies for improving opioid-related outcomes and implementation of these laws in Connecticut (CT).

methodsWe conducted six group model building (GMB) workshops that engaged a diverse set of participants with medical and community expertise and lived bystander experience. Through an iterative, stakeholder-engaged process, we developed, refined, and validated a qualitative system dynamics (SD) model in the form of a causal loop diagram (CLD).

resultsOur resulting qualitative SD model captures our GMB participants' collective understanding of the dynamics driving bystander behavior and other factors influencing the effectiveness of Good Samaritan Laws in the state of CT. In this model, we identified seven balancing (B) and eight reinforcing (R) feedback loops within four narrative domains: Narrative 1 - Overdose, Calling 911, and First Responder Burnout; Narrative 2 - Naloxone Use, Acceptability, and Linking Patients to Services; Narrative 3 - Drug Arrests, Belief in Good Samaritan Laws, and Community Trust in Police; and Narrative 4 - Bystander Naloxone Use, Community Participation in Harm Reduction, and Cultural Change Towards Carrying Naloxone.

conclusionsOur qualitative SD model brings a nuanced systems perspective to the literature on bystander behavior in the context of Good Samaritan Laws. Our model, grounded in local knowledge and experience, shows how the hypothesized non-linear interdependencies of the social, structural, and policy determinants of bystander behavior collectively form endogenous feedback loops that can be leveraged to design policies to advance and sustain systems change.

Indexed as

Harm ReductionOpiate OverdoseConnecticutDrug OverdoseHealth PolicyHumansLaw EnforcementNaloxoneNarcotic AntagonistsNaloxoneNarcotic AntagonistsGood Samaritan LawsHarm reductionOpioidsOpioid use disorderOverdoseSystem dynamics modelingSystems science

Identifiers

PMID38937759
PMCPMC11210010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.